Amar Patel is a Vice President at Enavate Sciences, where he leads the execution of investment opportunities and provides strategic and operational support to our partner companies. Previously, he was an investor on the biotech team at Longitude Capital. He started his career in the Healthcare Investment Banking group at J.P. Morgan. Amar currently serves as a board observer for several Enavate portfolio companies, including OrsoBio, Graviton Bioscience, Sudo Biosciences, and Sionna Therapeutics.

Amar graduated from the Roy and Diana Vagelos Program in Life Sciences and Management earning a B.A. in Neuroscience from the University of Pennsylvania and a B.S. in Finance from Wharton.

Return to Team